Based on the clinical evidence and the patient profiles where the compound appears most applicable, the following characteristics tend to describe good candidates for AOD 9604 evaluation when it is medically supervised: Patients with stubborn localized fat deposits that have not responded to diet and exercise, particularly visceral and lower abdominal fat Patients who cannot tolerate GLP-1 medications due to nausea, gastrointestinal side effects, or contraindications Active patients with reasonable baseline metabolic health who want a targeted lipolytic tool to complement their training and nutrition program Patients already on a peptide protocol who want to add a fat-targeting element to a GHK-Cu, NAD+, or sermorelin stack Patients who are not candidates for stimulant-based fat loss medications due to cardiovascular sensitivity, anxiety, or blood pressure concerns AOD 9604 is not appropriate as a standalone weight loss strategy for patients with significant obesity, insulin resistance, or metabolic syndrome
Both of these B-vitamins helps your body replicate cells
Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA Lipotropic Injections for Weight Loss Support Lipotropic injections are designed to support fat metabolism, boost energy, and enhance weight loss when combined with a healthy diet and lifestyle
Bermudez G, et al
This makes bromelain especially useful for individuals who consume high-protein diets or experience occasional digestive discomfort
It should be used in the dose and duration prescribed by your doctor
